Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2000
03/23/2000WO2000015212A2 Antifungal activity of dicationic molecules
03/23/2000WO2000008013A3 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
03/23/2000WO2000000198A8 Piperidine derivatives having effects on serotonin related systems
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999052892A3 Novel herbicides
03/23/2000CA2344445A1 Antifungal activity of dicationic molecules
03/23/2000CA2343111A1 Tube for lining pipes and channels, and a method and device for the production thereof
03/23/2000CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/22/2000EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/22/2000EP0987264A1 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
03/22/2000EP0987263A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
03/22/2000EP0987262A1 Quinoline derivatives
03/22/2000EP0987255A2 Substituted aminoquinazolinone (thione) derivatives
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0987253A1 Pyrazolone derivatives
03/22/2000EP0987251A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
03/22/2000EP0986553A1 Dihydropyrimidone derivatives as npy antagonists
03/22/2000EP0986551A1 Sulfonamide derivatives, their production and use
03/22/2000EP0986387A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
03/22/2000EP0986385A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986302A1 A method of treating cancer
03/22/2000EP0775114B1 Process for making antimicrobial compounds
03/22/2000CN1248254A Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for treatment of neurodegenerative and CNS-trauma related conditions
03/22/2000CN1248253A Tricyclic compounds useful for inhibition of farnesyl protein transferase
03/22/2000CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments
03/22/2000CN1248249A 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
03/22/2000CN1248248A Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists
03/22/2000CN1050600C Preparation of hexahydrotriazine compounds
03/21/2000US6040450 Reacting benzosulfide derivative with magnesium to form a magnesium halide containing benzosulfide derivative, reacting the intermediate with pyridine derivative to form intermediate, oxidizing and condensing the intermediate
03/21/2000US6040449 Useful for forming fluorine containing 1,4-disubstituted piperidine derivatives, useful as antagonist for muscarinic m3 receptors and less side effect
03/21/2000US6040331 Nerve cell protective agents
03/21/2000US6040327 Benzimidazole, benzoxazole and benzothiazole compounds
03/21/2000US6040320 Antiinflammatory agent for treating diseases associated with overproduction of inflammatory cytokines, such as rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, and osteoarthritis
03/21/2000US6040318 Treating insulin resistant non-insulin-dependent diabetes mellitus and ageing-associated obesity, neurogenic inflammation associated with neuropathy or rheumatoid arthritis
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040316 Tachykinin antagonists treating pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorders, inflammatory diseases, gastrointestinal disorders, vascular disorders, and neuropathological disorders
03/21/2000US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal
03/21/2000US6040305 Enzyme inhibitor as antitumor agent treating pancreatic tumor, lung cancer, myeloid leukemia, thyroid follicular tumor, myelodysplastic tumor, epidermal carcinoma tumor, bladder tumor, colon tumor, breast tumor, prostate tumor
03/21/2000US6040302 1,4-disubstituted piperazines
03/21/2000US6039683 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
03/21/2000CA2282885A1 New cationic 4-hydroxyindoles, their application in keratin fibre oxidation dye, dye compositions and dyeing methods
03/21/2000CA2000468C Piperidinyl benzimidazoles
03/16/2000WO2000014172A1 Electrochromic device with a yellow filter
03/16/2000WO2000014089A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014070A1 Antimalarial compounds
03/16/2000WO2000014069A1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000WO2000013681A2 4-quinolinemethanol derivatives as purine receptor antagonists (i)
03/16/2000WO2000008014A8 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect
03/16/2000WO2000005206A8 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
03/16/2000CA2343536A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2343144A1 Cyclohexenonequinolinoyl-derivatives as herbicidal agents
03/16/2000CA2342994A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/15/2000EP0985667A1 Novel dihydropyridine derivative
03/15/2000EP0985666A1 Substituted indole compounds as COX-2 inhibitors
03/15/2000EP0984961A1 Novel pyridine derivatives and pharmaceutical compositions containing them
03/15/2000EP0984960A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984958A1 Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
03/15/2000EP0984957A1 NOVEL FORM OF $i(S)OMEPRAZOLE
03/15/2000EP0984956A1 Indoline derivatives as 5ht2c receptor antagonists
03/15/2000EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS
03/15/2000EP0984944A1 Substituted 4-(3-alkenyl-benzoyl)-pyrazoles
03/15/2000EP0984943A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/15/2000EP0984779A1 Somatostatin agonists
03/15/2000EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
03/15/2000EP0739204A4 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
03/15/2000EP0664802B1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
03/15/2000EP0619805B1 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1050355C Fused bicyclic pyrimidinones comound and fungicidal compsn. containing same and its application
03/14/2000US6037356 Anticoagulants; antiinflammatory and antiarthritic agents
03/14/2000US6037354 Administering phenyl-substituted thiazolidin-4-one or oxazolidin-2-one derivative to treat benign prostate hyperplasia; side effect reduction
03/14/2000US6037352 N-substituted piperidine derivatives; treating alzheimer*s disease, nervous system disorders; acetylcholinesterase inhibitors
03/14/2000US6037350 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
03/14/2000US6037166 Enzymatic kinetic resolution of an intermediate useful for preparing substituted tricyclics
03/14/2000US6037157 Method for improving pharmacokinetics
03/14/2000CA2009542C Cyclic guanidines as calcium antagonists
03/09/2000WO2000012808A1 Method of treating a textile
03/09/2000WO2000012667A1 Composition and method for bleaching a substrate
03/09/2000WO2000012500A2 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands
03/09/2000WO2000012499A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012496A1 Novel cdk inhibitors having flavone structure
03/09/2000WO2000012489A1 1, 2, 4-triazole-3-thione compounds
03/09/2000WO2000012484A1 Tan-1057 derivatives
03/09/2000WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012091A1 Remedies for spinal canal stenosis
03/09/2000WO2000012089A1 Novel angiogenesis inhibitors
1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 1080